Creative Financial Designs’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6
Closed -$234 2164
2025
Q3
$234 Hold
6
﹤0.01% 1980
2025
Q2
$140 Hold
6
﹤0.01% 1969
2025
Q1
$91 Hold
6
﹤0.01% 2028
2024
Q4
$110 Hold
6
﹤0.01% 1768
2024
Q3
$68 Hold
6
﹤0.01% 1667
2024
Q2
$57 Hold
6
﹤0.01% 1632
2024
Q1
$200 Hold
6
﹤0.01% 1626
2023
Q4
$163 Hold
6
﹤0.01% 1573
2023
Q3
$370 Hold
6
﹤0.01% 1450
2023
Q2
$623 Hold
6
﹤0.01% 1408
2023
Q1
$1.08K Hold
6
﹤0.01% 1302
2022
Q4
$2.36K Hold
6
﹤0.01% 1141
2022
Q3
$2K Hold
6
﹤0.01% 1190
2022
Q2
$2K Hold
6
﹤0.01% 1154
2022
Q1
$3K Hold
6
﹤0.01% 1144
2021
Q4
$3K Hold
6
﹤0.01% 1108
2021
Q3
$3K Hold
6
﹤0.01% 1276
2021
Q2
$3K Hold
6
﹤0.01% 1292
2021
Q1
$5K Hold
6
﹤0.01% 1075
2020
Q4
$3K Hold
6
﹤0.01% 1101
2020
Q3
$3K Hold
6
﹤0.01% 1064
2020
Q2
$4K Hold
6
﹤0.01% 941
2020
Q1
$3K Hold
6
﹤0.01% 440
2019
Q4
$3K Hold
6
﹤0.01% 497
2019
Q3
$4K Buy
+6
New +$4.99K ﹤0.01% 509

Other funds holding TVRD

Creative Financial Designs's TVRD Position: Q4 2025 in Review

Creative Financial Designs sold out of Tvardi Therapeutics (TVRD) in Q4 2025, closing a stake of 6 shares — an estimated $234 sold.

Creative Financial Designs first reported a position in TVRD in Q3 2019 and held it in 25 quarters. The position peaked at $5K in Q1 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q4 2025.

  • Creative Financial Designs reported no remaining Tvardi Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Creative Financial Designs sold 6 Tvardi Therapeutics shares in Q4 2025, an estimated $234.
  • Creative Financial Designs first reported a position in Tvardi Therapeutics in Q3 2019 and held it in 25 quarters.
  • Creative Financial Designs's Tvardi Therapeutics position peaked at $5K in Q1 2021.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2025.

Based on Creative Financial Designs's 13F filing for Q4 2025, filed 6 Feb 2026.